Rosaced

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Rosaced

Property Description
Active Ingredient Metronidazole
Form Topical (Cream, Gel, or Lotion)
Pharmacological Class Nitroimidazole Antimicrobial and Antiprotozoal Agent
General Purpose Mitigates inflammatory skin irritation (e.g., redness, lesions)
Origin Synthetic Compound

What Type of Medicine is Rosaced?

Rosaced is a pharmaceutical preparation containing the active substance Metronidazole, classifying it as a nitroimidazole antimicrobial and antiprotozoal agent. This substance is a synthetic compound derived from the nitroimidazole class, which is clinically recognized for its efficacy against specific anaerobic microorganisms. Metronidazole functions as a prodrug, meaning it must undergo chemical activation within the target cells to become fully effective. The substance is recognized for its broad utility as a targeted antimicrobial. This demonstrates the drug's established importance in addressing infections and related conditions globally.

Beyond its primary function, Metronidazole possesses scientifically confirmed anti-inflammatory effects, a property supported by pharmacological studies. The topical compound acts to control microbial populations while also dampening inflammatory pathways. This means the medicine works in two distinct ways to relieve skin discomfort and lessen visible irritation.

Composition and Physical Form

The medicine is formulated for localized therapy, typically positioned for adult use. It is available as a single-agent product in several topical dosage forms, including a cream or an aqueous gel base. The active ingredient, Metronidazole, is suspended within a hydrophilic vehicle, enabling direct and concentrated application to the skin surface. This form, intended for the cutaneous route of administration, is designed to deliver the substance into the affected superficial layers. The advantage of a topical preparation, such as Rosaced, is its ability to focus the therapeutic effect precisely where it is needed, strictly limiting overall systemic absorption compared to oral medications.

General Therapeutic Purpose

The overall purpose of this medicine is rooted in its dual function: it manages the presence of specific micro-organisms while simultaneously acting against the inflammation these factors provoke. By providing both an antimicrobial function and an intrinsic soothing action, the preparation is generally intended to achieve a substantial reduction in symptoms such as skin redness and the development of inflammatory lesions. A typical use scenario involves applying the product to areas showing persistent, raised, inflamed skin bumps. This combined effect is the core benefit of the product, aimed at promoting localized skin relief and an improved physical appearance.

Regulatory References

  1. NIH MedlinePlus Drug Information on Metronidazole Topical

What side effects are possible with Rosaced?

Possible Side Effects and Safety Information

The safety profile of Rosaced, containing Metronidazole, is described by health authorities based on categorized adverse reactions and specific precautions. The most frequently observed events are related to the site of application.

Adverse Reaction Frequency

Adverse reactions listed in regulatory documents are grouped by the likelihood of occurrence:

  • Common Reactions: These include local skin discomfort, characterized by burning, stinging, or pain of the skin, along with dry skin, erythema (redness), pruritus (itching), skin irritation, and the worsening of rosacea.
  • Uncommon Reactions: Less frequent effects involve nervous system disorders such as a metallic taste (dysgeusia) and reduced sensation (hypoaesthesia or paraesthesia), as well as nausea.
  • Post-Marketing/Unknown Frequency: Reports include allergic reactions, contact dermatitis, tearing of the eyes (lacrimation), and a potentially serious adverse reaction, peripheral neuropathy.

Serious Adverse Reactions and Systemic Safety

While systemic absorption is minimal with topical use, regulatory documents require noting potential risks associated with the drug class. Peripheral neuropathy, characterized by numbness or tingling of the extremities, has been reported and requires reevaluation of therapy if observed. Caution is also advised when using this medicine in individuals with a history of blood disorders (dyscrasias) or central nervous system disease.

Safety Considerations for Specific Populations

Official labels state that the safety and effectiveness of topical metronidazole have not been established in pediatric patients. Use during pregnancy is permitted only if clearly needed. The product is strictly contraindicated in patients with a known hypersensitivity to metronidazole or any other components in the formulation. Contact with the eyes should be avoided to prevent irritation and tearing.

Overdose and Emergency Response

Rosaced Overdose and when to seek help — Official Regulatory Information

The regulatory profile for Rosaced (Topical Metronidazole) overdose emphasizes the potential for systemic exposure and the resulting need for specific emergency actions.

Overdose Scope

Property Official Regulatory Statement
Documented overdose presentations No human experience with overdosage of the topical formulation has been reported. However, topically applied metronidazole can be absorbed to produce systemic effects [1.4, 1.7].
Physiological systems affected Serious outcomes are primarily linked to the neurological system [1.4, 3.6].
Dose-related or exposure-related factors The risk is based on the potential for systemic absorption of the active ingredient [1.4].
Emergency-response statements Seek emergency medical attention for accidental swallowing (ingestion). Immediate reevaluation of therapy is mandated if abnormal neurologic signs appear [1.4, 2.1].
When immediate medical help is required Urgent help is required for suspected ingestion or the onset of abnormal neurological signs (e.g., numbness or paresthesia) [1.4, 2.1].

Overdose Classifications (High-Level)

Classification Property Official Regulatory Status
Severity classification Defined by the serious neurological risks associated with systemic metronidazole exposure, including convulsive seizures and peripheral neuropathy [3.1, 3.6].
Overdose-context constraints Management consists of symptomatic and supportive treatment, as no specific antidote is documented for metronidazole overdose [3.1, 2.4].

Resulting Overdose Structure

Official overdose statements:

  • The official label notes no reported human experiences with overdosage of the topical product.
  • Potential systemic risks include effects such as nausea, vomiting, ataxia, and serious neurological outcomes.
  • Seek emergency medical attention is required for suspected ingestion.
  • The appearance of abnormal neurologic signs mandates immediate reevaluation of therapy.

Connection to the overall overdose profile: Regulatory documents define the overdose profile by acknowledging the risk of systemic effects from the absorbed metronidazole, despite the limited topical overdose reports. The official guidance strictly mandates emergency action for accidental swallowing or the appearance of abnormal neurological signs, requiring immediate clinical reevaluation. The overall approach is supportive, reflecting the officially documented status that no specific antidote is available.

Therapeutic Uses of Rosaced

What Rosaced Treats: Main Uses and Benefits

This medicine is commonly used to treat rosacea, a chronic skin disease. It is applied across therapeutic domains where additional symptomatic support is needed to address the condition’s most noticeable features, which are symptoms related to inflammatory or irritative states.

The primary therapeutic focus is managing the visible manifestations of the condition, including the appearance of raised bumps (papules) and pus-filled blemishes (pustules), alongside its relevance for easing persistent facial redness (erythema). Rosaced is considered relevant in conditions characterized by periods of heightened symptoms, supporting the sustained, long-term management of the chronic condition. It assists with maintaining functional stability by managing the frequency and intensity of symptomatic flare-ups.

“The topical treatment is applied across domains where additional symptomatic support is needed to help ease the overall symptom burden of the most visible skin manifestations.”


Quick Fact: Relief for Inflammatory Lesions

This medication is commonly used to support patients during episodes of heightened discomfort, contributing to improved day-to-day comfort when symptoms are more noticeable.

Regulatory References

  1. NIH MedlinePlus Drug Information on Metronidazole Topical

Eligibility and Restrictions for Use

Who Can and Cannot Use Rosaced?

This section explains the official population eligibility and non-eligibility for Rosaced (Metronidazole Topical), as determined by government regulatory documents.

Eligibility Status Applicable Population Regulatory Classification
Use Allowed Adults with rosacea Indicated Population
Older adults Same dosage as adults
Contraindicated Individuals with known hypersensitivity to metronidazole or any other ingredient in the formulation Absolute Prohibition

Eligibility-Related Restrictions

Official prescribing information defines populations that require special consideration or limited use:

  • Pediatric Use: Safety and effectiveness have not been established in pediatric patients (children). Use is formally not recommended.
  • Pregnancy: Use is advised only if clearly needed by the physician, as adequate human studies are lacking, and metronidazole crosses the placental barrier.
  • Lactation: Breastfeeding is not recommended during treatment. The regulatory status requires a decision to discontinue nursing or discontinue the medicine.
  • Comorbid Conditions: The medicine must be used with care in patients with a history of blood dyscrasia (blood disorders) or Central Nervous System (CNS) diseases.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Rosaced (metronidazole topical) has low systemic absorption, but regulatory documents advise caution regarding interactions noted for oral metronidazole due to the potential for systemic exposure.


Documented Pharmacokinetic Interactions

Interaction Entity Official Regulatory Statement
Oral Anticoagulants (e.g., Warfarin) Metronidazole has been documented to potentiate the anticoagulant effect of coumarin derivatives, resulting in prolongation of prothrombin time. Caution is advised for patients receiving this combination.
Lithium Metronidazole may increase serum Lithium concentrations when co-administered systemically, a risk that requires consideration due to the potential for systemic exposure.
Phenytoin, Ciclosporin Metronidazole has been shown to increase plasma concentrations of Phenytoin and Ciclosporin (Cyclosporine), which necessitates awareness when used concurrently.

Substance-Related Restrictions

Alcohol (Ethanol): Consumption of alcoholic beverages is restricted during treatment and for a period (such as 72 hours) following the final dose. This mandatory restriction is due to the potential for a disulfiram-like reaction, characterized by symptoms like flushing, vomiting, and nausea.

Disulfiram: Although the topical route limits systemic exposure, Disulfiram is cited in regulatory documents as a substance to be approached with caution or avoided, as co-administration with oral metronidazole has been associated with psychotic reactions. The official interaction profile requires awareness of these systemic risks.

Mechanism of Action

The active molecule functions as a prodrug, requiring chemical transformation to become biologically active. This activation occurs via nitroreductase enzymes found in specific anaerobic microbes and protozoa, primarily within low-oxygen microenvironments. This process yields highly reactive intermediates that cause structural damage to the microbe's DNA. This targeted action ultimately results in the destruction of susceptible anaerobic microbial cells.

The drug simultaneously engages host immune pathways to exert an anti-inflammatory effect. It works by modulating neutrophil function—specifically by limiting the ability of these white blood cells to adhere to vessel walls and migrate into the inflamed tissue. Furthermore, it acts as a direct scavenger of Reactive Oxygen Species ( ROS), reducing the burden of oxidative damage and suppressing the local release of tissue-destructive mediators. These dual molecular actions lead to the physiological consequence of reduced inflammation and tissue exudation at the cutaneous level.

Dosage and Administration Information

How Rosaced is Used

Rosaced (metronidazole topical) is designated for cutaneous administration and is available in formulations such as a cream, gel, or lotion. The administration route is strictly localized to the skin and is not intended for ophthalmic, oral, or intravaginal use. The concentration of the active ingredient typically determines the dosing frequency. Formulations containing 0.75% metronidazole are generally applied twice daily, while the 1% concentration is often applied once daily.

The usage protocol requires applying a thin film of the product to the entire affected skin area. Instructions specify that the skin must be cleansed prior to application, and the hands must be thoroughly washed immediately before and after use. The product is solely intended for external use, and contact with mucous membranes, including the eyes and lips, should be avoided.

Treatment with metronidazole topical is typically conducted for a defined duration, often ranging between 9 and 12 weeks. The necessity for continued therapy must be re-evaluated by a healthcare professional if the initial course duration is exceeded. Furthermore, use in pediatric patients has not been established, although no specific dose adjustment is typically noted for older adult patients.

Recent Clinical Evidence

Research evidence / Overview of studies for Rosaced

Studies Examining Inflammatory Lesions (Papules and Pustules)

The clinical evaluation of topical metronidazole, the active ingredient in Rosaced, is largely composed of multiple Randomized Controlled Trials (RCTs). These short-to-intermediate-term studies were conducted in adult patients with rosacea, primarily focusing on those experiencing periods of heightened symptom activity, marked by the presence of raised bumps (papules) and pus-filled blemishes (pustules). Research examined the outcomes related to physical discomfort and how these symptoms change over defined observation intervals, with trials often comparing the active product against a non-medicated vehicle (placebo) cream or gel.

Studies monitored changes in the number of inflammatory lesions over defined time intervals, typically ranging from 8 to 12 weeks. Findings describe patterns observed in the studies related to changes measured in the physical discomfort associated with these lesions. Research has also explored the observed patterns in studies that included comparisons against other active agents.


Studies Examining Persistent Facial Redness (Erythema)

The clinical research included studies exploring outcomes linked to inflammatory or irritative states, specifically focusing on persistent facial redness (erythema). Researchers used clinician-rated severity scales to monitor physiological strain or stress. The studies monitored the extent of erythema using specialized scoring systems, reporting how the severity of redness scores changed in the observed populations.

However, the evidence is limited regarding patterns of change in the vascular component of rosacea. Studies consistently report that minimal or no change was observed in the appearance of telangiectasias (visible thread veins) over the observation period. Data are still emerging for patients whose primary or sole symptom is persistent redness without the presence of inflammatory lesions.


What Research Gaps and Uncertainties Remain

The research base contains specific limitations. Long-term outcomes are not well characterized beyond the initial six-month follow-up period. Research has not fully established a comprehensive scientific explanation of the exact physiological process studied in this condition. The results apply primarily to the populations studied, meaning that subgroup findings are uncertain for those with mild rosacea. Data remain limited for pediatric patients and pregnant or breastfeeding populations.

Frequently Asked Questions (FAQ)

Common questions about Rosaced (FAQ)


Q: How quickly do people typically notice an effect from Rosaced?

Clinical studies reviewed by regulatory bodies indicate that effects, such as a reduction in inflammatory lesions, are commonly observed within the first three weeks of beginning treatment. Researchers typically track progress and measure outcomes over a longer period, often ranging from 8 to 12 weeks.


Q: Does Rosaced cure the condition or just manage the symptoms?

Official descriptions and research summaries indicate that the medicine is primarily considered palliative, meaning its purpose is to manage the visible symptoms of the condition. It works to reduce irritation and lesions but does not appear to alter the underlying disease process itself.


Q: Can I use Rosaced at the same time as my regular moisturizer?

Regulatory instructions advise applying the product to cleansed skin, and suggest that the use of other topical products, such as moisturizers or creams, on the treated area should be minimized. If other products are used, regulatory sources suggest they should be applied only after the medication is reported to be dry.


Q: How long do most people continue using Rosaced?

The initial therapy course is typically conducted for a defined period, often around 8 to 12 weeks. However, regulatory information notes that ongoing, long-term therapy is frequently required for continuous management of inflammatory lesions associated with the condition.


Q: What does the patient leaflet say about stopping Rosaced use?

Regulatory documents caution that if treatment is discontinued, the inflammatory lesions and other symptoms may commonly recur. Official documents state that the necessity for continued therapy must be re-evaluated by a healthcare professional.


Q: What does the official description of Rosaced's effectiveness?

The effectiveness, based on clinical studies, is officially described as achieving a significant reduction in the count of inflammatory lesions (papules and pustules) when compared to using a non-medicated vehicle. These results are based on observed changes during defined study periods.


Q: Is it okay to wear makeup after applying Rosaced?

Official patient information states that cosmetics may be applied after the topical product, whether it is a gel or cream, has been applied and has fully dried on the skin.


Q: What happens if Rosaced is accidentally ingested?

In the case of accidental ingestion, regulatory first-aid information advises immediately attempting to dilute the product by drinking fluids, such as water or milk. Regulatory documents advise contacting a Poison Control Center or emergency services following accidental ingestion.


Q: Why are people often told to use Rosaced exactly as described?

Regulatory patient instructions caution that using the product more frequently or for a longer duration than described may cause unwanted side effects or skin irritation. The application protocol is established to balance therapeutic outcomes and minimize the chance of local adverse reactions.


Q: Is Rosaced safe for people with sensitive skin?

While the medicine is intended for topical use, regulatory documents list common local skin discomforts, including burning, stinging, dry skin, and irritation, as frequent adverse reactions. If significant skin irritation is observed, official information indicates that therapy may need to be modified or discontinued.


Q: What is the earliest age at which Rosaced has been studied?

The majority of the clinical studies that led to the drug's approval were conducted in adult patients. Official prescribing information states that the safety and effectiveness of the topical preparation have not been established in pediatric patients (children).


Q: What happens if I forget to use a dose of Rosaced?

If a dose is missed, patient information generally suggests applying it as soon as it is remembered. However, if it is almost time for the next scheduled dose, the missed application should typically be skipped to avoid using too much, and the regular schedule should be resumed.


Q: Is it common to have skin redness or irritation when first starting Rosaced?

Regulatory documents classify local skin discomforts such as erythema (redness), stinging, and irritation as common adverse reactions. These reactions frequently occur at the site of application during treatment, especially when first starting.


Q: Is it safe to use Rosaced if I'm trying to become pregnant?

Available data have not established a clear association between the topical metronidazole and adverse fetal outcomes. Official documents advise informing a healthcare provider if the patient is pregnant or planning to become pregnant.


Q: Does Rosaced make my skin more sensitive to the sun?

Official safety warnings advise patients to minimize exposure to sunlight, including sunlamps, during treatment. It is also recommended to use sunscreen products and protective clothing when sun exposure cannot be avoided.


Q: Is Rosaced available over the counter?

No, Rosaced (metronidazole topical) is classified by regulatory authorities as a prescription-only drug. It is only available to patients with a valid prescription from a healthcare professional.


Q: Is there a generic version of Rosaced available?

Government drug approval information indicates that the active ingredient, metronidazole topical, is available in generic formulations in addition to the brand name products.


Q: Why do some people report a burning sensation when applying Rosaced?

A burning or stinging feeling is classified in regulatory documents as a common adverse reaction. This is one of the frequently reported events related to the local skin reaction at the site of application.


Q: Can Rosaced be used on parts of the body other than the face?

The medication is approved for the treatment of rosacea, which is a condition involving the face. Official instructions refer to applying a thin film to the affected area(s), but the regulatory indication is specifically for the management of facial inflammatory lesions.


Q: What is the difference between Rosaced cream and Rosaced gel?

Regulatory documents confirm that the medicine is available in different topical forms, such as a cream and a gel. Both forms contain the same active ingredient and are effective, but the difference lies in the vehicle base, which may be chosen based on individual skin preferences.


Q: Can Rosaced affect the results of blood tests?

Topical use results in minimal systemic absorption into the bloodstream. While it does not state a direct effect on routine blood test results, regulatory information notes caution for patients with a history of certain blood disorders (dyscrasias) due to the drug class.


Q: Is the purpose of Rosaced purely cosmetic, or does it address an underlying issue?

The purpose is therapeutic, not purely cosmetic. The drug is classified as an antimicrobial agent that also possesses anti-inflammatory effects. Its action is to treat the underlying inflammatory process that results in visible lesions and redness.

How should Rosaced be stored and disposed of?

How to Store and Dispose of Rosaced? (Metronidazole Topical)

Topical metronidazole (Rosaced) must be stored according to regulatory requirements to ensure its stability.

Storage Requirements

Condition Regulatory Rule
Temperature Store at Controlled Room Temperature, which is 20 C to 25 C.
Protection Do not freeze. Protect the product from direct light and excess heat or moisture.
Container Keep in the closed container in which it was dispensed and keep it tightly closed.
Safety Store all medication out of the sight and reach of children.

Disposal

Do not keep outdated medicine. Unused or expired product should be disposed of according to local regulations. Authorities recommend using community drug take-back programs as the preferred method for safe disposal.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Rosaced found in:

A-Z Index: